Clinical Aspects of Invasive Candidiasis in the Surgical Patient

Drugs

Volumn 69, Issue , 2009, Pages 29-32

  Sganga, Gabriele ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anidulafungin; Colonization Index; Fluconazole; Invasive Candidiasis; Micafungin

Indexed keywords

CANDIDA; CANDIDIASIS; CATHETERIZATION; CROSS INFECTION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; MORTALITY; POSTOPERATIVE COMPLICATION; REVIEW; SURGICAL INFECTION;

CANDIDA; CANDIDIASIS; CATHETERIZATION; CROSS INFECTION; HUMANS; POSTOPERATIVE COMPLICATIONS; SURGICAL WOUND INFECTION;

EID: 75349114020     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11315600-000000000-00000     Document Type: Review

References (29)

1. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980— 1989. National Nosocomial Infections Surveillance System. Am J Med 1991 Sep 16; 91(3B): 86–9S
2. Borzotta AP, Beardsley K. Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999 Jun; 134(6): 657–64; discussion 64-5
3. Vincent JL, Anaissie E, Bruining H, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998 Mar; 24(3): 206–16
4. Dean DA, Burchard KW. Surgical perspective on invasive Candida infections. World J Surg 1998 Feb; 22(2): 127–34
5. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001 Jul 15; 33(2): 177–86
6. McKinnon PS, Goff DA, Kern JW, et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001 Dec; 136(12): 1401–8; discussion 9
7. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994 Sep; 170(3): 644–52
8. Eubanks PJ, de Virgilio C, Klein S, et al. Candida sepsis in surgical patients. Am J Surg 1993 Dec; 166(6): 617–9; discussion 9-20
9. Kratzer C, Tobudic S, Graninger W. Invasive candidiasis, Candida colonisation and antifungal treatment in intensive care patients after cardiothoracic surgery [abstract P1799]. 18th European Congress on Clinical Microbiology and Infectious Diseases; 2008 19–22 Apr; Barcelona
10. Patterson JE. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis 1999 Dec; 1(4): 229–36
11. Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998 Oct; 27(4): 781–8
12. Vindenes H, Bjerknes R. The frequency of bacteremia and fungemia following wound cleaning and excision in patients with large burns. J Trauma 1993 Nov; 35(5): 742–9
13. Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989 Dec 16; 2(8677): 1437–40
14. Grossi PA. Clinical aspects of invasive candidiasis in solid organ transplant recipients. Drugs 2009; 69 Suppl. 1: 15–20
15. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999 Aug; 29(2): 253–8
16. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007 Jan; 20(1): 133–63
17. Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003 May; 123 (5 Suppl.): 500–3S
18. Calandra T, Marchetti O. Clinical trials of antifungal prophylaxis among patients undergoing surgery. Clin Infect Dis 2004 Oct 15; 39 Suppl. 4: S185–92
19. Dupont H, Paugam-Burtz C, Muller-Serieys C, et al. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 2002 Dec; 137(12): 1341–6; discussion 7
20. Guery BP, Arendrup MC, Auzinger G, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis. Intensive Care Med 2009 Jan; 35(1): 55–62
21. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005 Sep; 49(9): 3640–5
22. Concia E, Azzini AM, Conti M. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 2009; 69 Suppl. 1: 5–14
23. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994 Dec; 220(6): 751–8
24. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999 Jun; 27(6): 1066–72
25. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001 Apr; 233(4): 542–8
26. Piarroux R, Grenouillet F, Balvay P, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004 Dec; 32(12): 2443–9
27. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009 Mar 1; 48(5): 503–35
28. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005 Nov; 31(11): 1479–87
29. Playford EG, Webster AC, Sorrell TC, et al. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006 Apr; 57(4): 628–38